Related Experiment Video
Updated: Sep 20, 2025
07:50
Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer
Published on: September 18, 2020
5.7K
CervicalMethDx: A Precision DNA Methylation Test to Identify Risk of High-Grade Intraepithelial Lesions in Cervical
Laura Palmieri1,2,3, Fernando T Zamuner1,3, Dieila Giomo de Lima1,3,4
1Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Cancer Prevention Research (Philadelphia, Pa.)
|May 29, 2025
Summary
The CervicalMethDx test accurately detects high-grade cervical lesions in HPV-positive women. This DNA methylation test shows high sensitivity and specificity, aiding in appropriate colposcopy referrals for cervical cancer prevention.
Area of Science:
- Oncology
- Genetics
- Biotechnology
Background:
- Cervical cancer remains a significant global health challenge for women.
- Current screening methods like cytologic tests and HPV detection require improved triage strategies.
- Accurate identification of high-grade cervical lesions is crucial for timely intervention.
Purpose of the Study:
- To validate the CervicalMethDx test as a reflex test for HPV-positive women.
- To assess the test's performance in classifying cervical intraepithelial neoplasia grade 2 (CIN2) and grade 3 (CIN3) lesions.
- To evaluate the test's potential to improve triage to colposcopy.
Main Methods:
- A blinded retrospective study using well-characterized clinical samples.
- Quantitative real-time methylation-specific PCR (qMSP) to assess DNA methylation in specific gene promoters.
- Machine learning algorithms applied to DNA methylation data for classification.
Main Results:
- CervicalMethDx correctly classified 95% of CIN2 samples with 91% sensitivity and 100% specificity.
- The test achieved 94% classification for CIN3 samples with 90% sensitivity and 100% specificity.
- Combined CIN2/CIN3 samples were classified with 93% sensitivity, 97% specificity, and an AUC of 0.96.
Conclusions:
- CervicalMethDx demonstrates strong discriminatory power for identifying CIN2/CIN3 risk.
- The test can complement existing triage strategies for colposcopy referral.
- Further prospective, population-based studies are needed for broader evaluation, especially in low-resource settings.
